Rachel J. Quin

429 total citations
15 papers, 365 citations indexed

About

Rachel J. Quin is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Rachel J. Quin has authored 15 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Rachel J. Quin's work include Glycosylation and Glycoproteins Research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Galectins and Cancer Biology (4 papers). Rachel J. Quin is often cited by papers focused on Glycosylation and Glycoproteins Research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Galectins and Cancer Biology (4 papers). Rachel J. Quin collaborates with scholars based in Australia, United States and India. Rachel J. Quin's co-authors include Michael A. McGuckin, Peter L. Devine, Bruce G. Ward, David J. Munster, D. C. Gotley, Pei‐Xiang Xing, J D Fontenot, Michelle Wykes, B. Ward and Kelli P. A. MacDonald and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Cancer and Journal of Leukocyte Biology.

In The Last Decade

Rachel J. Quin

14 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel J. Quin Australia 8 271 140 127 65 48 15 365
Yiling Mi United States 9 267 1.0× 114 0.8× 62 0.5× 31 0.5× 55 1.1× 14 387
Selvi Ramasamy United States 5 256 0.9× 156 1.1× 54 0.4× 100 1.5× 28 0.6× 8 377
Weichen Qi China 3 337 1.2× 129 0.9× 122 1.0× 74 1.1× 101 2.1× 6 417
V. Kroezen Netherlands 9 263 1.0× 111 0.8× 85 0.7× 75 1.2× 14 0.3× 12 390
T Irimura Japan 8 239 0.9× 90 0.6× 55 0.4× 79 1.2× 80 1.7× 8 344
J Spielman United States 10 204 0.8× 309 2.2× 25 0.2× 59 0.9× 42 0.9× 12 437
Hailing Yan United States 10 246 0.9× 100 0.7× 142 1.1× 132 2.0× 7 0.1× 16 525
Heather C. Workman United States 7 160 0.6× 98 0.7× 49 0.4× 86 1.3× 21 0.4× 8 293
Jeffrey Johnson United States 11 206 0.8× 46 0.3× 94 0.7× 181 2.8× 44 0.9× 30 404
Kersti Klaamas Estonia 12 275 1.0× 277 2.0× 215 1.7× 58 0.9× 19 0.4× 23 463

Countries citing papers authored by Rachel J. Quin

Since Specialization
Citations

This map shows the geographic impact of Rachel J. Quin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel J. Quin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel J. Quin more than expected).

Fields of papers citing papers by Rachel J. Quin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel J. Quin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel J. Quin. The network helps show where Rachel J. Quin may publish in the future.

Co-authorship network of co-authors of Rachel J. Quin

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel J. Quin. A scholar is included among the top collaborators of Rachel J. Quin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel J. Quin. Rachel J. Quin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wykes, Michelle, Kelli P. A. MacDonald, Mai H. Tran, et al.. (2002). MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells. Journal of Leukocyte Biology. 72(4). 692–701. 72 indexed citations
2.
Quin, Rachel J. & Michael A. McGuckin. (2000). Phosphorylation of the cytoplasmic domain of the MUC1 mucin correlates with changes in cell-cell adhesion. International Journal of Cancer. 87(4). 499–506. 64 indexed citations
3.
Munster, David J., et al.. (1999). The MUC3 Gene Encodes a Transmembrane Mucin and Is Alternatively Spliced. Biochemical and Biophysical Research Communications. 261(1). 83–89. 76 indexed citations
4.
Devine, Peter L., et al.. (1998). Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women. Cancer Immunology Immunotherapy. 46(5). 245–252. 54 indexed citations
5.
Devine, Peter L., et al.. (1998). Serum Mucin Antigen (CASA) as a Marker of Amiodarone‐Induced Pulmonary Toxicity. Disease Markers. 14(3). 169–175. 2 indexed citations
6.
Munster, David J., Rachel J. Quin, Amolak S. Bansal, Bruce G. Ward, & Michael A. McGuckin. (1998). Peritoneal fluid from ovarian cancer patients stimulates MUC1 epithelial mucin expression in ovarian cancer cell lines. International Journal of Cancer. 76(3). 393–398. 4 indexed citations
7.
McGuckin, Michael A., Rachel J. Quin, & B. Ward. (1998). Progesterone stimulates production and secretion of MUC1 epithelial mucin in steroid-responsive breast cancer cell lines.. International Journal of Oncology. 12(4). 939–45. 27 indexed citations
8.
Walsh, Michael D., Michael A. McGuckin, Rachel J. Quin, et al.. (1996). Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate disease.. PubMed. 10(4). 221–5. 3 indexed citations
9.
Devine, Peter L., Geoffrey W. Birrell, Rachel J. Quin, John Hayman, & Paul Shield. (1995). Production of CEA-Reactive Monoclonal Antibody (4E7) and Its Applications in Immunochemistry. Hybridoma. 14(4). 397–399.
10.
Devine, Peter L., Michael A. McGuckin, Rachel J. Quin, & B. G. Ward. (1995). Predictive value of the combination of serum markers, CAI 25, CASA and TPS in ovarian cancer. International Journal of Gynecological Cancer. 5(3). 170–178. 16 indexed citations
11.
Devine, Peter L., Michael D. Walsh, Michael A. McGuckin, et al.. (1995). Prostate-specific Antigen (PSA) and Cancer-Associated Serum Antigen (CASA) in Distinguishing Benign and Malignant Prostate Disease. The International Journal of Biological Markers. 10(4). 221–225. 3 indexed citations
12.
Devine, Peter L., et al.. (1995). CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer. Breast Cancer Research and Treatment. 34(3). 245–251. 21 indexed citations
13.
Devine, Peter L., Rachel J. Quin, & Hiroshi Harada. (1994). Monoclonal Antibodies Reacting with the Mucin-Specific Lectin from Sambucus sieboldiana (SSA-M). Hybridoma. 13(4). 323–325. 1 indexed citations
14.
Devine, Peter L., Geoffrey W. Birrell, Rachel J. Quin, & Paul Shield. (1994). Monoclonal Antibodies Recognising Sialyl‐Tn: Production and Application to Immunochemistry. Disease Markers. 12(3). 175–186. 4 indexed citations
15.
Devine, Peter L., Michael A. McGuckin, Rachel J. Quin, & Bruce G. Ward. (1994). Serum Markers CASA and CA15-3 in Ovarian Cancer: All MUC1 Assays Are Not the Same. Tumor Biology. 15(6). 337–344. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026